1. Home
  2. ARWR vs SBCF Comparison

ARWR vs SBCF Comparison

Compare ARWR & SBCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • SBCF
  • Stock Information
  • Founded
  • ARWR 2003
  • SBCF 1926
  • Country
  • ARWR United States
  • SBCF United States
  • Employees
  • ARWR N/A
  • SBCF N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • SBCF Major Banks
  • Sector
  • ARWR Health Care
  • SBCF Finance
  • Exchange
  • ARWR Nasdaq
  • SBCF Nasdaq
  • Market Cap
  • ARWR 1.8B
  • SBCF 2.1B
  • IPO Year
  • ARWR 1993
  • SBCF N/A
  • Fundamental
  • Price
  • ARWR $18.31
  • SBCF $29.29
  • Analyst Decision
  • ARWR Buy
  • SBCF Buy
  • Analyst Count
  • ARWR 8
  • SBCF 4
  • Target Price
  • ARWR $43.71
  • SBCF $29.25
  • AVG Volume (30 Days)
  • ARWR 1.6M
  • SBCF 696.4K
  • Earning Date
  • ARWR 08-07-2025
  • SBCF 07-24-2025
  • Dividend Yield
  • ARWR N/A
  • SBCF 2.46%
  • EPS Growth
  • ARWR N/A
  • SBCF 6.66
  • EPS
  • ARWR N/A
  • SBCF 1.48
  • Revenue
  • ARWR $545,209,000.00
  • SBCF $506,381,000.00
  • Revenue This Year
  • ARWR $21,924.50
  • SBCF $23.90
  • Revenue Next Year
  • ARWR N/A
  • SBCF $25.88
  • P/E Ratio
  • ARWR N/A
  • SBCF $19.80
  • Revenue Growth
  • ARWR 1436.97
  • SBCF N/A
  • 52 Week Low
  • ARWR $9.57
  • SBCF $21.36
  • 52 Week High
  • ARWR $30.41
  • SBCF $31.68
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 66.51
  • SBCF 69.84
  • Support Level
  • ARWR $16.45
  • SBCF $28.50
  • Resistance Level
  • ARWR $19.24
  • SBCF $29.73
  • Average True Range (ATR)
  • ARWR 0.79
  • SBCF 0.78
  • MACD
  • ARWR 0.25
  • SBCF 0.21
  • Stochastic Oscillator
  • ARWR 77.43
  • SBCF 86.17

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage and credit facilities.

Share on Social Networks: